论文部分内容阅读
医药行业在WTO条款中相关的承诺主要有四条,这四项条款支撑起来的“保护伞”并不那么安全。 一是药品知识产权保护。我国将落实对100多个成员国都要实行知识产权保护的规定。按照知识产权保护的有关条款,在专利期内仿制某种新药,开发方有权索取4-10亿美元的赔款,若买断一个专利新药的生产许可,则需支付500-600万美元。
There are mainly four commitments made by the pharmaceutical industry in the WTO clauses, and the “umbrella” supported by these four clauses is not so safe. First, drug intellectual property protection. My country will implement the provisions on the protection of intellectual property rights for more than 100 member states. In accordance with the relevant provisions of intellectual property protection, imitation of a new drug during the patent period, the developer has the right to claim 4-10 million in compensation, if the purchase of a patent for new drug production permit, you will have to pay 500-600 million.